AlphaCentric Advisors’s Globus Medical GMED Stock Holding History
Bought
Maintained
Sold
Other funds holding GMED
AlphaCentric Advisors's GMED Position: Q3 2026 in Review
AlphaCentric Advisors held its Globus Medical (GMED) position steady in Q3 2026 at 10,000 shares worth $749K. The position accounts for 0.67% of the portfolio, ranked #37.
AlphaCentric Advisors first reported a position in GMED in Q2 2020 and has held it in 12 quarters since. The position peaked at $2M in Q4 2024. 617 funds tracked by Wall St. Rank hold GMED as of Q3 2026.
- AlphaCentric Advisors held 10,000 shares of Globus Medical worth $749K as of Q3 2026.
- AlphaCentric Advisors left its Globus Medical share count unchanged in Q3 2026.
- Globus Medical made up 0.67% of AlphaCentric Advisors's portfolio in Q3 2026, its #37 holding.
- AlphaCentric Advisors first reported a position in Globus Medical in Q2 2020 and has held it in 12 quarters since.
- AlphaCentric Advisors's Globus Medical position peaked at $2M in Q4 2024.
- 617 funds tracked by Wall St. Rank held Globus Medical as of Q3 2026.
Based on AlphaCentric Advisors's 13F filing for Q3 2026, filed 3 Nov 2026.